Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F
Institute of General Pathology, University of Ferrara, Italy.
J Exp Med. 1997 Feb 3;185(3):579-82. doi: 10.1084/jem.185.3.579.
Microglial cells express a peculiar plasma membrane receptor for extracellular ATP, named P2Z/P2X7 purinergic receptor, that triggers massive transmembrane ion fluxes and a reversible permeabilization of the plasma membrane to hydrophylic molecules of up to 900 dalton molecule weight and eventual cell death (Di Virgilio, F. 1995. Immunol. Today, 16:524-528). The physiological role of this newly cloned (Surprenant, A., F. Rassendren, E. Kawashima, R. A. North and G. Buell, 1996. Science (Wash. DC). 272:735-737) cytolytic receptor is unknown. In vitro and in vivo activation of the macrophage and microglial cell P2Z/P2X7 receptor by exogenous ATP causes a large and rapid release of mature IL-1 beta. In the present report we investigated the role of microglial P2Z/P2X7 receptor in IL-1 beta release triggered by LPS. Our data suggest that LPS-dependent IL-1 beta release involves activation of this purinergic receptor as it is inhibited by the selective P2Z/P2X7 blocker oxidized ATP and modulated by ATP-hydrolyzing enzymes such as apyrase or hexokinase. Furthermore, microglial cells release ATP when stimulated with LPS. LPS-dependent release of ATP is also observed in monocyte-derived human macrophages. It is suggested that bacterial endotoxin activates an autocrine/paracrine loop that drives ATP-dependent IL-1 beta secretion.
小胶质细胞表达一种特殊的细胞外ATP质膜受体,称为P2Z/P2X7嘌呤能受体,该受体可触发大量跨膜离子通量,并使质膜对分子量高达900道尔顿的亲水性分子产生可逆通透性,最终导致细胞死亡(迪·维尔吉利奥,F. 1995年。《免疫学年鉴》,16:524 - 528)。这种新克隆的(苏普雷南特,A.,F. 拉森德伦,E. 川岛,R. A. 诺思和G. 比尔,1996年。《科学》(华盛顿特区)。272:735 - 737)溶细胞受体的生理作用尚不清楚。外源性ATP在体外和体内激活巨噬细胞和小胶质细胞的P2Z/P2X7受体,会导致成熟IL - 1β大量快速释放。在本报告中,我们研究了小胶质细胞P2Z/P2X7受体在脂多糖触发的IL - 1β释放中的作用。我们的数据表明,脂多糖依赖性IL - 1β释放涉及该嘌呤能受体的激活,因为它受到选择性P2Z/P2X7阻滞剂氧化ATP的抑制,并受到诸如腺苷三磷酸双磷酸酶或己糖激酶等ATP水解酶的调节。此外,小胶质细胞在用脂多糖刺激时会释放ATP。在单核细胞衍生的人巨噬细胞中也观察到脂多糖依赖性ATP释放。有人提出细菌内毒素激活了一个自分泌/旁分泌环,该环驱动ATP依赖性IL - 1β分泌。